共 176 条
- [1] Alanio A(2020)Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19 Lancet Respir Med 8 e48-e49
- [2] Dellière S(2020)Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis Eur Respir J 56 2002554-509
- [3] Fodil S(2008)Delaying amphotericin b-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis Clin Infect Dis 47 503-513
- [4] Bretagne S(2020)Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet 395 507-2629
- [5] Mégarbane B(2020)Clinical and immunologic features in severe and moderate coronavirus disease 2019 J Clin Invest 130 2620-405
- [6] Armstrong-James D(2015)The role of adjunctive therapies in the management of invasive sino-orbital infection Ophthal Plast Reconstr Surg 31 401-e421
- [7] Youngs J(2019)Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium Lancet Infect Dis 19 e405-542
- [8] Bicanic T(2019)Invasive fungal sinusitis: risk factors for visual acuity outcomes and mortality Ophthalmic Plast Reconstr Surg 35 535-534
- [9] Abdolrasouli A(2020)COVID-19 associated pulmonary aspergillosis Mycoses 63 528-e80
- [10] Denning DW(2020)Rhino-orbital mucormycosis associated with COVID-19 Cureus 12 e40-2468